Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN MEXICOThe improving regulatory environment and the increasing foreign direct investment make Mexico's pharmaceutical market more attractive to multinational drugmakers. We project an increase in government healthcare spending to further boost the number of procedures and expand access to medicines in its national health insurance programme. However, the potential deceleration of the country's macroeconomic growth may dampen the country's pharmaceutical market prospects. Generic drug competition and counterfeit medicines are also key concerns for multinationals pharmaceutical companies. Headline Expenditure Projections Pharmaceuticals: MXN161.45bn (US$12.99bn) in 2011 to MXN175.82bn (US$13.47bn) in 2012; +8.9% in local currency terms and +3.7% in US dollar terms. Forecasts increase from Q4 12 due to macroeconomic factors. Healthcare: MXN872.57bn (US$70.21bn) in 2011 to MXN951.98bn (US$72.95bn) in 2012; +9.1% in local currency terms and +3.9 % in US dollar terms. F orecasts increase from Q4 12 due to macroeconomic factors. Medical devices: MXN52.05bn (US$4.19bn) in 2011 to MXN57.85bn (US$4.43bn) in 2012; +11.1% in local currency terms and +5.9% in US dollar terms. F orecasts increase from Q4 12 due to macroeconomic factors. Risk/Reward Rating: The Pharmaceutical and Healthcare Risk/Reward Rating (RRR) in Q113 for Mexico remains the same (58.4) as in Q412. Mexico still ranks the fourth out of the 17 Americas markets surveyed in our proprietary regional RRR rating system above Brazil, indicating a more optimistic outlook for Mexican market.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Mexico, Business Monitor International
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MEXICO
The improving regulatory environment and the increasing foreign direct investment make Mexico's pharmaceutical market more
attractive to multinational drugmakers. We project an increase in government healthcare spending to further boost the number of
procedures and expand access to medicines in its national health insurance programme. However, the potential deceleration of the
country's macroeconomic growth may dampen the country's pharmaceutical market prospects. Generic drug competition and
counterfeit medicines are also key concerns for multinationals pharmaceutical companies.
Headline Expenditure Projections
Pharmaceuticals: MXN161.45bn (US$12.99bn) in 2011 to MXN175.82bn (US$13.47bn) in 2012; +8.9% in local currency terms and
+3.7% in US dollar terms. Forecasts increase from Q4 12 due to macroeconomic factors.
Healthcare: MXN872.57bn (US$70.21bn) in 2011 to MXN951.98bn (US$72.95bn) in 2012; +9.1% in local currency terms and +3.9 %
in US dollar terms. F orecasts increase from Q4 12 due to macroeconomic factors.
Medical devices: MXN52.05bn (US$4.19bn) in 2011 to MXN57.85bn (US$4.43bn) in 2012; +11.1% in local currency terms and
+5.9% in US dollar terms. F orecasts increase from Q4 12 due to macroeconomic factors.
Risk/Reward Rating: The Pharmaceutical and Healthcare Risk/Reward Rating (RRR) in Q113 for Mexico remains the same (58.4)
as in Q412. Mexico still ranks the fourth out of the 17 Americas markets surveyed in our proprietary regional RRR rating system
above Brazil, indicating a more optimistic outlook for Mexican market.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 8
SWOT Analysis 10
Mexico Pharmaceuticals And Healthcare Industry SWOT 10
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Mexico Political SWOT 11
Mexico Economic SWOT 11
Mexico Business Environment SWOT 12
Pharmaceutical Risk/Reward Ratings 13
Table: Americas Pharmaceutical And Healthcare Risk/Reward Ratings, Q113 13
Rewards 15
Risks 15
Mexico ' Market Summary 17
Regulatory Regime 19
Marketing Registration 20
Table: Legal Pharmaceutical Registration Requirements 21
Table: Legal Pharmaceutical Registration Requirements 21
Import Regulation 22
Table: Import Fees 23
Table: Registration Renewal Requirements 23
Release Of Manufacturing Requirements 23
Regulation Of Antibiotics 24
Post-Marketing 24
Advertising 25
Biologics And Biosimilar Guideline 26
Research & Development 29
Table: NOM-177-SSA1-1998's Generic Tests 32
Intellectual Property Rights 32
Intellectual Property Environment 34
IP Shortcomings 35
Table: Mexican Marketing Applications In Alleged Violation Of Patent Rights 36
Counterfeit Drugs 37
Pricing & Reimbursement 38
Reimbursement 40
Pricing Issues 41
Pricing Developments 43
Reimbursement Issues 44
Other Regulatory Developments 44
Industry Trends and Developments 46
Epidemiology 46
Non-Communicable Diseases 47
Healthcare Sector 47
Health Insurance 48
Healthcare Sector Funding 50
Medical Tourism 50
Research & Development 51
Clinical Trials 53
Table: Clinical Trial Regulation In Mexico 54
Table: Clinical Studies, 2003-09 56
Medical Devices 57
Industry Forecast Scenario 58
Overall Market Forecast 58
Table: Pharmaceutical Sales Indicators 2008-2016 59
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Key Growth Drivers ' Industry 60
Table: Healthcare Expenditure Indicators 2008-2016 61
Table: Healthcare Governmental Indicators 2008-2016 62
Table: Healthcare Private Indicators 2008-2016 62
Key Growth Drivers ' Macroeconomic 64
Table: Mexico Macro Indicators 69
Prescription Drug Market Forecast 70
Table: Prescription Drug Sales Indicators 2008-2016 71
Patented Drug Market Forecast 72
Table: Patented Drug Market Indicators 2008-2016 73
Generic Drug Market Forecast 74
Table: Generic Drug Sales Indicators, 2008-2016 76
Associations 76
Table: Members of AMEGI, 2011 77
Members of ANAFAM, 2011 78
OTC Medicine Market Forecast 80
Table: OTC Medicine Sales Indicators 2008-2016 82
Pharmaceutical Trade Forecast 83
Table: Exports and Imports Indicators 2008-2016 84
Medical Device Market Forecast 86
Table: Medical Devices Sales Indicators, 2008-2016 86
Other Healthcare Data 87
Key Risks To BMI's Forecast Scenario 87
Competitive Landscape 89
Pharmaceuticals Industry 89
Pharmaceutical Company Activity 90
Foreign Competition 90
Table: Members of AFAMELA, 2012 90
Table: Members of AMIIF, 2012 91
Table: Members of CANIFARMA, 2012 93
Table: AstraZeneca's Sales, 2005-10 96
Pharmaceutical Distribution Sector 104
Wholesale 104
DIPROFAR 104
Grupo Casa Saba 104
Marzam 105
NADRO 106
Pharmaceuticals Retail Sector 107
Table: IMSS Pharmacies, 2000-11 107
Table: IMSS Financial Indicators, 2000-11 (MXNmn) 109
Table: Leading Pharmaceutical Suppliers to IMSS, 2010-12 (MXNmn) 110
Table: IMSS Expenditure on Disease & Maternity Insurance by State, 2011 (MXNmn) 110
ISSSTE 112
Table: ISSSTE's Pharmaceutical Expenditure, 2006-12 112
Seguro Popular 113
Table: SPSS Budget, 2004-11 (MXNmn) 114
Table: FPGC Disease Groups, 2011 115
Table: FPGC Cases & Cost By Disease, Authorised In 2011, Validated And Paid By December 31 2011 116
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Associations of Independent Pharmacies 118
Table: Members of ANADIM, 2012 119
Members of ANEFAR, 2012 120
Pharmacy Chains 121
Farmacias del Ahorro 121
Farmacias Benavides 121
Table: Farmacias Benavides' Key Indicators, 2003-11 122
Farmacias El Fenix 122
Corporativo Fragua 123
Table: Corporativo Fragua's Key Indicators, 2005-11 123
Farmacias Similares 124
Walmart 125
Company Profiles 127
Local Company Profiles 127
Genomma Labs 127
Multinational Companies 131
Pfizer 131
GlaxoSmithKline (GSK) 133
Sanofi 135
Eli Lilly 138
Bristol-Myers Squibb 140
Novartis 142
Bayer 145
Boehringer Ingelheim 147
Merck KGaA 150
Roche Syntex 152
Demographic Outlook 155
Mexico - Population By Age Group 156
Mexico - Population By Age Group 157
Mexico - Key Population Ratios 158
Mexico - Rural and Urban Population 158
Glossary 159
BMI Methodology 161
How We Generate Our Pharmaceutical Industry Forecasts 161
Pharmaceutical Risk/Reward Ratings Methodology 162
Ratings Overview 162
Table: Pharmaceutical Risk/Reward Indicators 163
Weighting 164
Table: Weighting Of Components 164
Sources 164
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Mexico, Business Monitor International
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Mexico, Business Monitor International (From Slideshare) Page 6/6